Product Information
PREGABALIN 150 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0505 per EA under NDC 64980041409. Its NADAC has been published 358 times since Aug 21, 2019.
Strength
150 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980041409
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA210432On Market Since
7/19/2019
Price Statistics
The NADAC for PREGABALIN 150 MG CAPSULE has been published 358 times since Aug 21, 2019, and over the history we have for it it has declined 73.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0505 per EA |
|---|---|
| All-time high | $0.1892 (Sep 11, 2019) |
| All-time low | $0.0494 (Nov 20, 2024) |
| 52-week high | $0.0691 |
| 52-week low | $0.0505 |
| Median price | $0.0804 |
| Average price | $0.0940 |
| Largest weekly change | +32.6% (Aug 21, 2024) |
| Weeks tracked | 358 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PREGABALIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 150 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0505 per EA (NDC 64980041409), effective Jun 24, 2026.
How has the price of PREGABALIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 150 MG CAPSULE has declined 73.3%. It has been tracked across 358 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for PREGABALIN 150 MG CAPSULE?
Since Aug 21, 2019, the NADAC for PREGABALIN 150 MG CAPSULE has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.1892 (Sep 11, 2019), with a median of $0.0804 per EA.
Are there cheaper alternatives to PREGABALIN 150 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as PREGABALIN 150 MG CAPSULE, but none are currently priced below it.
Who manufactures PREGABALIN 150 MG CAPSULE?
PREGABALIN 150 MG CAPSULE (NDC 64980041409) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification